EDCTP Call for Proposals: Innovative approaches to enhance poverty-related diseases research
The European & Developing Countries Clinical Trials Partnership (EDCTP) opened a call for proposals “Innovative approaches to enhance poverty-related diseases research” with the purpose to fund a number of small- to medium-scale clinical trials and/or clinical research studies that can deliver proof-of-concept or validation of smart, highly innovative technologies or concepts to prevent, treat or diagnose poverty-related diseases (PRDs) in sub-Saharan Africa.
Objectives:
- Provide pilot data to advance the testing of new technologies in future large-scale studies
- Generate results to inform the design of larger-scale studies
- Accelerate the development of new, low-cost, easy-to-implement solutions to address barriers to progress
- Strengthen research capacity of institutions to introduce and implement new technologies
- Increase collaboration with (development) partners, including increasing leverage of funding
- Contribute to creating solutions for improved development or delivery of medical interventions for vulnerable populations in low resource settings.
Eligibility:
- its content corresponds, wholly or in part, to the topic/contest description for which it is submitted
- it complies with the eligibility conditions for participation set out below, depending on the type of action:
- At least three legal entities. Two of the legal entities shall be established in two different Participating States (European Partner States) and one of the legal entities must be established in a sub-Saharan African country. All three legal entities must be independent of each other.
- ‘Sole participants’ formed by several legal entities (e.g. European Research Infrastructure Consortia, European Groupings of Territorial Cooperation, central purchasing bodies) are eligible if the above-mentioned minimum conditions are satisfied by the legal entities forming together the sole participant.
Read more here.
Proposals deadline August 13, 2020.
